EIF2AK3 and breast carcinoma: Blocking PERK and JNK pathways attenuated SB-T-101141-induced cell death, while inhibiting the p38MAPK pathway further enhanced SB-T-101141 efficacy in cell death, suggesting the protective function of p38MAPK activation for breast cancer cells to resist SB-T-101141 cytotoxicity.